# Cetoleic acid and other long-chain unsaturated fatty acids as neuroprotective nutraceuticals

**Authors:** Patrik Anthony Tang, Maria José Ruiz-Pastor, Aurélia E. Lewis, Kari Espolin Fladmark, Asgeir Kobro-Flatmoen, Øyvind Halskau, Pradeep Lal

PMC · DOI: 10.1186/s12944-026-02876-8 · Lipids in Health and Disease · 2026-02-16

## TL;DR

This paper reviews how certain long-chain fatty acids, like cetoleic acid, may protect brain health and influence other beneficial fatty acids.

## Contribution

The paper highlights the potential neuroprotective role of cetoleic and erucic acids and identifies gaps in understanding their mechanisms.

## Key findings

- Cetoleic acid may positively affect neurological health based on cell line studies.
- Erucic and cetoleic acids influence the availability of neuroprotective fatty acids like DHA and EPA.
- Current research lacks detailed mechanisms of how these fatty acids exert neuroprotective effects.

## Abstract

Long-chain monounsaturated fatty acids such as erucic acid, cetoleic acid and gondoic acid, are 20-22-carbon fatty acids with a double bond in their ω-9, ω-11 and ω-9 positions, respectively. Recent experimental research suggests that these lipids may provide benefits related to cardiovascular, but also brain health. Research on cetoleic acid using cell lines suggests that this fatty acid may positively affect neurological health. Also, in limited doses, erucic acid and gondoic acid have been reported to have a neuroprotective effect through action on peroxisome proliferator-activated receptors, and monounsaturated fatty acids generally are able to influence these receptors. Herein, we review the current state of knowledge of monounsaturated fatty acids effect on health, with an emphasis on erucic acid and cetoleic acid and their possible neuroprotective effects. Research has not progressed far regarding the direct neuroprotective effects of cetoleic acid, and mechanisms underlying such effects. However, both erucic and cetoleic acid influence the availabilities of docosahexaenoic and eicosapentaenoic acids, that do confer several health benefits, including neuroprotective effects. We highlight knowledge gaps related to metabolism, putative neuroprotective mechanisms, and briefly review animal model systems suitable for investigating these gaps.

## Linked entities

- **Chemicals:** cetoleic acid (PubChem CID 5282771), erucic acid (PubChem CID 5281116), gondoic acid (PubChem CID 5282768), docosahexaenoic acid (PubChem CID 445580), eicosapentaenoic acid (PubChem CID 5282847)

## Full-text entities

- **Chemicals:** monounsaturated fatty acids (MESH:D005229), fatty acid (MESH:D005227), 20-22-carbon fatty acids (-), lipids (MESH:D008055), erucic acid (MESH:C049811), gondoic acid (MESH:C572289), eicosapentaenoic acids (MESH:D015118), Cetoleic acid (MESH:C015058)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13001258/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13001258/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC13001258/full.md

---
Source: https://tomesphere.com/paper/PMC13001258